# A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema

> **NCT01934556** · PHASE1,PHASE2 · COMPLETED · sponsor: **Palmetto Retina Center, LLC** · enrollment: 150 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Ranibizumab 0.3 mg intravitreal injection
- **DEVICE:** Guided Laser Photocoagulation

## Key facts

- **NCT ID:** NCT01934556
- **Lead sponsor:** Palmetto Retina Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-04
- **Final completion:** 2018-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934556, "A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01934556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*